NDC Code | 70461-318-03 |
Package Description | 10 SYRINGE, GLASS in 1 CARTON (70461-318-03) > .5 mL in 1 SYRINGE, GLASS (70461-318-04) |
Product NDC | 70461-318 |
Product Type Name | VACCINE |
Proprietary Name | Flucelvax Quadrivalent (prefilled Syringe) |
Non-Proprietary Name | Influenza A Virus A/singapore/gp1908/2015 Ivr-180 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza A Virus A/north Carolina/04/2016 (h3n2) Hemagglutinin Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza B Virus B/iowa/06/2017 Hemagglutinin Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza B Virus B/singapore/inftt-16-0610/2016 Hemagglutinin Antigen (mdck Cell Derived, Propiolactone Inactivated) |
Dosage Form | INJECTION, SUSPENSION |
Usage | INTRAMUSCULAR |
Start Marketing Date | 20160523 |
End Marketing Date | 20190731 |
Marketing Category Name | BLA |
Application Number | BLA125408 |
Manufacturer | Seqirus, Inc. |
Substance Name | INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/NORTH CAROLINA/04/2016 (H3N2) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/IOWA/06/2017 HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) |
Strength | 15; 15; 15; 15 |
Strength Unit | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |